A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsies.
<h4>Background</h4>A major perspective for the use of circulating tumor DNA (ctDNA) in the clinical setting of non-small cell lung cancer (NSCLC) is expected as predictive factor for resistance and response to EGFR TKI therapy and, especially, as a non-invasive alternative to tissue biop...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/ff998aa9327d45aaa5565f0293d06c8b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!